Literature DB >> 33989640

First case of cyproterone acetate induced multiple meningiomas in identical female twins: A case report.

V Batchinsky-Parrou1, S Barraud2, J C Kleiber3, F Litre3.   

Abstract

Meningiomas are the most common tumors of the central nervous system. Most meningiomas are benign and occur mainly in middle-aged women. Only a few cases of meningiomas in identical twins have been reported. Cyproterone acetate (Androcur® Bayer Healthcare SAS) (CPA) is an antiandrogenic progestin used to treat female hirsutism in some countries including France. We report a case of identical twin sisters who developed multiple, atypically located meningiomas in the setting of long-term CPA use. Eighteen-month follow-up showed spontaneous decrease of meningiomas after cessation of CPA. This case illustrates CPA's ability to induce development of atypically located meningiomas that differ even between identical twins, confirms benefit of surgical abstention, and raises questions regarding security of use of CPA.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Androcur; Cyproterone acetate; Meningioma; Twins

Mesh:

Substances:

Year:  2021        PMID: 33989640     DOI: 10.1016/j.neuchi.2021.04.021

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  1 in total

1.  Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization.

Authors:  Thibault Passeri; Lorenzo Giammattei; Tuan Le Van; Rosaria Abbritti; Alexandre Perrier; Jennifer Wong; Christine Bourneix; Marc Polivka; Homa Adle-Biassette; Anne-Laure Bernat; Julien Masliah-Planchon; Emmanuel Mandonnet; Sébastien Froelich
Journal:  Acta Neurochir (Wien)       Date:  2021-10-06       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.